INTRODUCTION
Transfusion institutions strive to provide blood products that are microbiologically safe and compatible with recipient blood characteristics. Achieving this goal requires stringent pre-transfusion screening at two levels. The first level involves blood cell antigens. To date, the International Society Blood Transfusion (ISBT) has recorded a total of 339 blood group specificities including 297 in 33 systems (Reid et al. 2012) . Since the ABO and Rh antigens can be immunologically significant due to the presence of natural ABO antibodies and strong immunogenicity of the RHD antigen, systematic ABO-RhD typing is necessary. The second level of pre-transfusion screening involves identification of Rh-Kell antigenic profiles and, to a lesser extent, Duffy, Kidd and Ss phenotype. Screening for the latter phenotypes is necessary depending on the patient, pathology and risk of alloimmunization.
In addition to ensuring transfusion safety, awareness of antigen frequency in a given population is crucial to defining product requirements and minimum stock levels. Given the high variability of red cell antigens, transfusion institutes must determine antigen frequencies in the population that they serve. Such determination is especially important in population settings like Afghanistan (Witzel 1999) . In Kabul, the Central Blood Bank (BCS, Banque Centrale du Sang) was established in the 1980s, but political unrest, lack of funding and policy matters forced closure between 1992 and 1995. Since 1995, the BCS has been working to maintain a sound basis for a selfsufficient blood transfusion system under the auspices of four government ministries: Health, Defense, National Security, and Home Affairs.
The Etablissement Français du Sang Alpes-Méditerranée (EFS-AM) has been deeply involved in the rehabilitation of the BCS in Kabul. In 1999, an initial study conducted in collaboration with the EFS-AM presented the serological profile and blood characteristics of the population living in the Afghan capital (Dupire et al. 1999) . In 2008, the EFS-AM with the support of the Agence Nationale de la Recherche implemented the AFGHAPOP program in a larger sample of the Afghan population in surrounding areas. The twofold goal of AFGHAPOP was to describe genetic diversity based on anthropological genetic markers and improve the safety of blood transfusion in Afghanistan.
The present report describes results obtained in a cohort of blood donors originating from the main Afghan communities studied within the framework of the AFGHANPOP program. The primary study objective was to define the frequency of key antigens (ABO, Rh, Kell) and prevalence of other blood group genes for blood transfusion. The secondary objective was to gain better insight into the distribution of red cell antigens in human populations and highlight the correlated anthropological and environmental factors.
MATERIAL AND METHODS

Sample collection
This study was approved by the Afghan authorities and CNRS ethics committee. Blood collection was performed after obtaining informed consent in 5 Afghan populations living in the mountainous Hindu-Kush region: Hazara, Pashto, Uzbek, Tajik and Turkmen. To allow accurate interpretation of the Afghan dataset in the geographical and anthropological context, 168 additional DNA samples from 8 Pakistani populations (Hazara, Kalash, Makrani, Balochi, Brahui, Burusho, Pathan and Sindhi) were obtained from the Centre d'Etude du Polymorphisme Humain (HGDP-CEPH) (Cann et al. 2002) .
Surface antigen typing
A total of 507 blood samples were selected for red cell antigen typing of the ABO, Rh, and Kell blood group systems. Typing was carried out in Kabul with Diagast (France) reagents anti-A (Clone 9113D10), -B (Clone 9621A8), -AB (Clones 9113D10 + 152D12), and -D (Clones P3x61 + P3x21223B10 + P3x290 + P3x35); and Eurobio (France) reagents anti-C (Clones MS273), -c (Clone MS35), -E (Clones MS12 + MS260), -e (MS62 + MS69) and -K (Clone AEK4).
Blood group genotyping by two Singleplex PCR
Genomic DNA was extracted from whole blood samples using the QIAamp DNA Blood Mini Kit (Qiagen) and stored at -20°C (-4°F). Genotyping of both Afghan and Pakistani samples was performed using two multiplex PCRs at the EFS-AM in Marseilles, France with focus on 17 polymorphisms coding for MNS, Kell, Duffy, Kidd, Cartwright, Dombrock, Indian, Colton, Diego and Landsteiner-Wiener red cell antigens of transfusion and anthropological interest. The first one was designed for simultaneous detection of 11 SNPs of the GYPB (MNS), KEL (KEL), FY (FY), SLC14A1 (JK), ACHE (YT), DO (DO), AQP1 (CO) genes whose red cell antigens are strongly implicated in transfusion reactions (Daniels et al. 2004; Di Cristofaro et al. 2010) . 1 for final concentration). Amplification was performed under stringent conditions: 96°C for 5 minutes for 1 cycle; 94°C for 30 seconds, 64°C for 30 seconds, 72°C for 1 minute for 30 cycles, followed by one 10-minute-long cycle at 72°C. PCR amplicon purification were described elsewhere (Di Cristofaro et al. 2010) . Probe primer extensions for the SNaPshot reaction are presented in Table 1 .
Primer extension reactions were segregated by capillary electrophoresis on an automated fluorescencebased ABI PRISM 3130 XL genetic analyzer according to manufacturer's protocol.
In order to check accuracy and reproducibility of the multiplex SNaPshot assay presented here, the genotypes not included in the first multiplex (Di Cristofaro et al. 2010) were validated with known phenotypes obtained by serology and sequencing. For the crossmatch of the results using serology, only the anti-Fya (Clone DG-FYA-02, Diagast, France) and anti-Fyb (polyclonal, Diagast, France) antibodies were available. In addition, the validation was enhanced using 41 representative homozygotes and heterozygotes from our collection to act as control samples by direct sequencing. 
Statistical analysis
Red cell antigen frequencies were calculated by direct counting. ABO allele frequencies were estimated from the ABO phenotypes using Bernstein's method that calls for direct counting in the case of genotypes with recessive alleles (Bernstein 1925) . By default we labeled the traditional ABO*A.01, ABO*B.01 and ABO*O.01.01 alleles as the ones coding for the observe phenotypes. RH haplotype frequencies were estimated from the RH phenotypes using the Expectation-Maximization (EM) algorithm in the GENE[RATE] package (Nunes 2006) . Assuming the Hardy-Weinberg equilibrium, this procedure enables to estimate the maximum-likelihood haplotype frequencies from multi-locus genotype data and considers all possibilities of genotypic ambiguities, that is when several genotypes can lead to the same phenotype (Dempster et al. 1977) . The EM algorithm was done with 1000 iterations of all possible haplotype combinations.
Population comparison was performed between data obtained using Bernstein's method and the EM algorithm and previous ABO, Rh and Kell data including Western Europeans, Sub-Saharans, 983 West Asians, circa 43,000 South Asians and an undefined number of East Asians described in the literature (Cavalli-Sforza et al. 1994; Nanu and Thapliyal 1997; Dupire et al. 1999; Asadov et al. 2003; Periyavan et al. 2010; Thakral et al. 2010; Keramati et al. 2011; Radzhabov et al. 2011; Reid et al. 2012) .
RESULTS
Data obtained by serological ABO, Rh and Kell antigen testing observed in the Afghan samples are given in Table 2 , and the inferred allele frequencies in Table 3 . The last five columns of Table 3 present the allele frequencies observed in the main Western European, Sub-Saharan, and Asian populations. A striking feature of the ABO system in the Afghan populations studied here was the predominance of the phenotype B (range: 25-32%) and frequency of the ABO*B.01 allele (range, 21-25%). Higher AB phenotype frequencies were observed in the Uzbek, Tajik, Turkmen and Pashto ethnic groups (13-15%) than in the Hazara group (4%). The O phenotype was found in 26 to 35% of the individuals serotyped and the estimated ABO*O.01.01 allele frequency ranged between 50 and 60%.
Regarding Rh phenotypes, the frequency of D-ranged from 6% in the Pashto, and Tajik groups to 16% in the Hazara group. Three D-phenotypes were observed: D-C+E-c+e+ in two Hazaras and one Turkmen, D-C-E+c+e+ in one Tajik, and the ubiquitous D-C-E-c+e+ that ranged from 6% (n=5) in the Pashto to 13% (n= 10) in the Hazara. A total of four D+ phenotypes were encountered in the five Afghan populations. The most frequent D+ phenotype was D+C+E-c-e+ (range, 31-37%) followed by D+C+E-c+e+ (range, 22-33%), D+C+E+c+e+ (range 16-19%) and D+C-E+c+e+ (range, 6% to 14%).
Based on the estimates inferred from the RH phenotypes using the EM algorithm of GENE[RATE] (Dempster et al. 1977; Nunes 2006) , the three most prevalent haplotypes in the five Afghan populations were DCe, dce and DcE, accounting for 51-54%, 24-29% and 13-19% respectively. The Dce haplotype ranged from 3 to 4% in the Pashto, Tajik and Uzbek groups and the dCe haplotype ranged from 3 to 5% in the Hazara and Turkmen groups. The DCE haplotype, which is characteristic of Asian populations (1-3%), was observed only in the Pashto (1%) and Tajik (2%) groups. Only the Tadjiik group carried the European-specific dcE haplotype (1%). The dCE haplotype was not detected in any of the five Afghan populations.
With regard to the Kell system, the K antigen was detected in all five ethnic groups. Its frequency ranged from one case (1%) each in the Tajik and Turkmen groups up to seven cases in the Uzbek group (6%). alleles were ubiquitously found, and conversely the GYPB*03N.03 and GYPB*03N.02 alleles were not encountered. The two latter were not included in Table 4 . Seven alleles were sporadically detected with a frequency of less than 4%: KEL*01.1, KEL*02.06, FY*02M.01, DI*01, IN*01, LW*07 and CO*02. KEL*02.06 coding for the Js a antigen was observed in one heterozygous Tajik, and IN*01 responsible for the In a antigen was detected in one heterozygous Tajik and one heterozygous Burusho.
DI*01 was observed in 6 populations (Pashto, Tajik, Turkmen, Balochi, Hazara and Sindhi) between 1% and 3%. CO*02 was spotted in the Hazara (1%), the Turkmen (1%) and the Burusho (2%). The frequency of the FY*02N.01 allele was low in Afghan samples (range, 1 to 5%) but interestingly reached 12% in the Baloshi and 18% in the Makrani from Pakistan. After cross-validation with the raw data and using the EM algorithm supplied in the GENE[RATE] package (Nunes 2006) , we could ensure that they all FY silent mutations were associated with the Fy b -specific polymorphism. Lastly, JK*01 and YT*01 ranged respectively between 48% (Burusho) and 73% (Kalash), and 84% (Pathan) and 100% (Brahui).
DISCUSSION
The present study provides serologic frequencies in order to ensure safe blood transfusion in Afghanistan. We especially performed two multiplex molecular analyses which amplified simultaneously alleles coding for RBC antigens either major for transfusion and anthropological purposes in the same Afghan populations enriched with DNA samples from Pakistan. These molecular arrays turned to be preferentially employed because they were low-cost, fast, and avoided the clinical shortcomings of the hemagglutination-based assays (Di Cristofaro et al. 2010) . Importantly, no discordance was observed between the phenotype inferred from the SNaPshot genotyping and the control samples, so we assume that the method herein presented covered accurately the DNA regions of interest.
We then compared the frequencies obtained with that of the main geographical areas of interest (Table 3) , and the following patterns were outstanding. The mean frequency of the ABO*B.01 allele was higher in Afghan populations than in Sub-Saharan (13%) and Eurasian (7-20%) populations. Similar frequencies have been reported in South and Central Asia (25-35%) (Mourant et al. 1958; Abawi et al. 2001; Keramati et al. 2011 ). In addition, the D-C-E-c+e+ phenotype and the Furthermore, Central and South Asia are known to be the original reservoir of cholera (Sack et al. 2004 ) and plague bacteria (Achtman et al. 2004) , and the southern coast of Pakistan has been defined as a malaria transmission area (WHO 2011). Since RBC antigens can act as fixation sites for infectious organisms (Telesmanich et al. 2008; Howes et al. 2011) , it is plausible that directive selection played a role in the evolution of the different human antigenic profiles, notably in our region of study. Previously attempts suggested that individuals who can make anti-H were likely to be more resistant to the plague and cholera (Garraty 2005; Harris et al. 2005; Telesmanich et al. 2008) . The high frequency of the B phenotype in our samples does not contradict this plausible hypothesis. Also, the higher presence in the Makrani of the FY silent allele could offer a selective advantage against Plasmodium vivax. Nonetheless, we detected in the Makrani samples 14% of the Fya-/Jkb-/Sphenotype; a component found in 31.5% in Africans as opposed to only 4.5% of Europeans (Noizat-Pirenne 2003) , and the Makrani were further documented by 39.4% of mitochondrial haplotypes of African origin (Quintana-Murci et al. 2004) . In this regard, our data are consistent with the notion of overlapping blood group allele frequencies between Western Eurasia and East Asia, gene exchanges, and probably positive selection.
For the last two decades, there have been several blood group surveys in the urban populations of Afghanistan which have mainly highlighted major failures in the blood handling coupled with a worrying microbiological situation (Todd et al. 2007; Ayyoubi et al. 2010; Khan and Attaullah 2011) .
Compatibility screening in Afghanistan is currently restricted to the ABO, RHD, and K key antigens (Dupire et al. 1999; Abawi et al. 2001) . In emergency situations, e.g. after bombing, it is limited to ABO compatibility only without detection of HIV, HBV, or HCV viral markers. These practices must be considered as extremely hazardous, noticeably because of the vaccination rate against hepatitis in the country, a high level of drug use in urban areas, and several high-risk cultural practices including tattooing (Todd et al. 2007; Khan and Attaullah 2011) . Fewer than half of emerging countries perform pre-donation medical interviewing to identify risk factors and post-collection testing to detect viral markers (Dupire et al. 1999) . To further enhance safety, the commercially ELISA combo test should be used in order to prevent HIV and HCV contamination by blood products.
The present study provided a wide array of RBC antigens in Afghan donors and Pakistani populations in the ethnographic and blood transfusion contexts of Afghanistan. These study's findings, which were forwarded to the NBC in Kabul, emphasized how crucial the estimation of biological diversity is in a panel of Afghan donors in defining standards for safe blood collection and release in the area. Table 1 . Primer and probe sequences used for blood group amplification in the 10-pair multiplex PCR (Bruce et al. 1994; Hermand et al. 1995; Lee et al. 1995; Tournamille et al. 1995a; Tournamille et al. 1995b; Telen et al. 1996; Gubin et al. 2000; Rios et al. 2002) . Table 2 . Occurrence and frequencies of the ABO, Rh and Kell phenotypes in five Afghan populations Table 3 . Allele and haplotype frequencies of the ABO, Rh and Kell blood group systems in five Afghan populations compared to published data. (Cavalli-Sforza et al. 1994; Nanu and Thapliyal 1997; Dupire et al. 1999; Asadov et al. 2003; Periyavan et al. 2010; Thakral et al. 2010; Keramati et al. 2011; Radzhabov et al. 2011; Reid et al. 2012) . Table 4 . Frequencies of 15 biallelic polymorphisms in five Afghan and eight Pakistani populations. Table 1 . Primer and probe sequences used for blood group amplification in the 10-pair multiplex PCR (Bruce et al. 1994; Hermand et al. 1995; Lee et al. 1995; Tournamille et al. 1995a; Tournamille et al. 1995b; Telen et al. 1996; Gubin et al. 2000; Rios et al. 2002 Table 3 . Allele and haplotype frequencies of the ABO, Rh and Kell blood group systems in five Afghan populations compared to published data. (Cavalli-Sforza et al. 1994; Nanu and Thapliyal 1997; Dupire et al. 1999; Asadov et al. 2003; Periyavan et al. 2010; Thakral et al. 2010; Keramati et al. 2011; Radzhabov et al. 2011; Reid et al. 2012 
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